Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cuadrado

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Clinical and Experimental Rheumatology|June 24, 2005
Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetilC N Pisoni, G Obermoser, M J Cuadrado, et al.
Annals of the Rheumatic Diseases|May 22, 2003
Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritisP Alba, L Bento, M J Cuadrado, et al.
The Journal of Rheumatology|June 9, 2005
Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patientsCecilia N Pisoni, Francisco J Sanchez, Yousuf Karim, et al.
Minerva Medica|December 17, 2009
Clinical guidelines for the management of acute viral infections in patients with systemic lupus erythematosusM Ramos-Casals, M J Cuadrado, P Alba, et al.
Medicine|July 13, 2005
Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?José A Gómez-Puerta, Helena Martín, Mary-Carmen Amigo, et al.
Lupus|February 10, 2011
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodiesG Ruiz-Irastorza, M J Cuadrado, I Ruiz-Arruza, et al.
Lupus|August 3, 2017
Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune diseaseD Erkan, O Unlu, S Sciascia, et al.
Autoimmunity Reviews|January 29, 2014
14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trendsDoruk Erkan, Cassyanne L Aguiar, Danieli Andrade, et al.
Expert Opinion on Biological Therapy|July 11, 2022
Preventing organ damage in systemic lupus erythematosus: the impact of early biological treatmentÍñigo Rua-Figueroa Fernández de Larrinoa, María J Cuadrado Lozano, Carlos Marras Fernández-Cid, et al.
Kidney International Reports|April 18, 2023
Clinical-Pathological Characteristics of Renal Injuries Identify Different Clusters in Patients With Antiphospholipid AntibodiesSavino Sciascia, Jinoos Yazdany, Gabriella Moroni, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Clinical and Experimental Rheumatology|June 24, 2005
Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetilC N Pisoni, G Obermoser, M J Cuadrado, et al.
Annals of the Rheumatic Diseases|May 22, 2003
Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritisP Alba, L Bento, M J Cuadrado, et al.
The Journal of Rheumatology|June 9, 2005
Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patientsCecilia N Pisoni, Francisco J Sanchez, Yousuf Karim, et al.
Minerva Medica|December 17, 2009
Clinical guidelines for the management of acute viral infections in patients with systemic lupus erythematosusM Ramos-Casals, M J Cuadrado, P Alba, et al.
Medicine|July 13, 2005
Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?José A Gómez-Puerta, Helena Martín, Mary-Carmen Amigo, et al.
Lupus|February 10, 2011
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodiesG Ruiz-Irastorza, M J Cuadrado, I Ruiz-Arruza, et al.
Lupus|August 3, 2017
Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune diseaseD Erkan, O Unlu, S Sciascia, et al.
Autoimmunity Reviews|January 29, 2014
14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trendsDoruk Erkan, Cassyanne L Aguiar, Danieli Andrade, et al.
Expert Opinion on Biological Therapy|July 11, 2022
Preventing organ damage in systemic lupus erythematosus: the impact of early biological treatmentÍñigo Rua-Figueroa Fernández de Larrinoa, María J Cuadrado Lozano, Carlos Marras Fernández-Cid, et al.
Kidney International Reports|April 18, 2023
Clinical-Pathological Characteristics of Renal Injuries Identify Different Clusters in Patients With Antiphospholipid AntibodiesSavino Sciascia, Jinoos Yazdany, Gabriella Moroni, et al.
Pageof 8